HealthEquity (HQY) Competitors

CDK Global (NASDAQ:CDK) and HealthEquity (NASDAQ:HQY) are both mid-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, risk, earnings, dividends and media sentiment.

Which has higher earnings and valuation, CDK or HQY?

CDK Global has higher revenue and earnings than HealthEquity. CDK Global is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CDK Global	$1.67B	3.82	$1.03B	$2.09	26.20
HealthEquity	$999.59M	7.11	$55.71M	$0.64	127.63

Which has more risk and volatility, CDK or HQY?

CDK Global has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Is CDK or HQY more profitable?

CDK Global has a net margin of 14.28% compared to CDK Global's net margin of 5.57%. HealthEquity's return on equity of 67.84% beat CDK Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CDK Global	14.28%	67.84%	11.15%
HealthEquity	5.57%	6.91%	4.41%

Does the MarketBeat Community believe in CDK or HQY?

HealthEquity received 148 more outperform votes than CDK Global when rated by MarketBeat users. Likewise, 69.24% of users gave HealthEquity an outperform vote while only 56.11% of users gave CDK Global an outperform vote.

Company	Underperform	Outperform
CDK Global	Outperform Votes 363 56.11%	Underperform Votes 284 43.89%
HealthEquity	Outperform Votes 511 69.24%	Underperform Votes 227 30.76%

Does the media favor CDK or HQY?

In the previous week, HealthEquity had 3 more articles in the media than CDK Global. MarketBeat recorded 6 mentions for HealthEquity and 3 mentions for CDK Global. CDK Global's average media sentiment score of 1.04 beat HealthEquity's score of 0.08 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CDK Global	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthEquity	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals believe in CDK or HQY?

92.9% of CDK Global shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.5% of CDK Global shares are owned by company insiders. Comparatively, 2.2% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Do analysts rate CDK or HQY?

HealthEquity has a consensus price target of $96.17, indicating a potential upside of 17.74%. Given CDK Global's higher probable upside, analysts plainly believe HealthEquity is more favorable than CDK Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CDK Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
HealthEquity	0 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

HealthEquity beats CDK Global on 10 of the 17 factors compared between the two stocks.